Director / PDMR Shareholding

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care, central laboratory and molecular diagnostics business, was informed on 1 October 2014 that David Evans, Executive Chairman, purchased shares in the Company on 1 October 2014.

David purchased 100,000 ordinary shares of 1 pence each in EKF at a purchase price of 23 pence per share.

David’s total shareholding following this purchase is 1,805,753 ordinary shares, which represents 0.43% of the Company’s issued share capital.

Back to Listing Previous Next

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.